ACRUE: A Phase 2, Open-Label Study of Acalabrutinib in Combination With Rituximab in Elderly and/or Frail Patients With Treatment-Naive Diffuse Large B- Cell Lymphoma

被引：0
|
作者：
Perini, Guilherme F. [1 ]
Graff, Tara [2 ]
Roos, Jack [3 ]
Hermann, Richard [3 ]
Lovenklev, Magnus [4 ]
Shaw, Bob [5 ]
Budde, Lihua E. [6 ]
机构：
[1] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
[2] Mission Blood & Canc, Des Moines, IA USA
[3] AstraZeneca, Gaithersburg, MD USA
[4] AstraZeneca, Stockholm, Sweden
[5] AstraZeneca, Cambridge, England
[6] City Hope Natl Med Ctr, Duarte, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
ABCL; acalabrutinib; frail elderly; lymphoma; large B-cell; diffuse; progression-free survival; rituximab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-192
引用
收藏
页码：S462 / S462
页数：1
相关论文
共 50 条
  • [1] Acrue: A Phase 2, Open-Label Study of Acalabrutinib in Combination with Rituximab in Elderly and/or Frail Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma
    Perini, Guilherme F.
    Graff, Tara
    Roos, Jack
    Hermann, Richard
    Lovenklev, Magnus
    Shaw, Bob
    Budde, L. Elizabeth
    BLOOD, 2023, 142
  • [2] Traverse: A Phase 2, Open-Label, Randomized Study of Acalabrutinib in Combination with Venetoclax and Rituximab in Patients with Treatment-Naive Mantle Cell Lymphoma
    Hawkes, Eliza A.
    Fletcher, Rachel
    Wood, Andrew
    Meyer, Stefanie
    Rule, Simon
    Zhang, Jingyang
    Wang, Michael L.
    BLOOD, 2023, 142
  • [3] Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study
    Strati, Paolo
    Champion, Rebecca
    Coleman, Morton
    Smith, Sonali M.
    Venugopal, Parameswaran
    Martin, Peter
    Wood, Andrew
    Miller, Kara
    Christian, Beth
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2248 - 2253
  • [4] A Phase 2, Open-Label Study of Loncastuximab Tesirine in Combination With Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients With Diffuse Large B-Cell Lymphoma (LOTIS-9)
    Westin, Jason
    Burke, John M.
    Chapman, Andrew E.
    Kilavuz, Turk
    Xu, Cindy
    Shmuely, Yochi
    Radford, John
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S368 - S368
  • [5] A Phase 2, Open-Label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-9)
    Westin, Jason
    Burke, John M.
    Chapman, Andrew E.
    Kilavuz, Turk
    Xu, Cindy
    Schmuely, Yochi
    Stanford, Brad Lane
    Beedle, Emily
    Radford, John
    BLOOD, 2022, 140 : 6638 - 6639
  • [6] Safety and Efficacy of Acalabrutinib Plus Venetoclax and Rituximab in Patients With Treatment-Naive Mantle Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (02) : 6 - 7
  • [7] A Multicenter Open-Label, Phase 1b/2 Study of Ibrutinib in Combination with Lenalidomide and Rituximab in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Goy, Andre
    Ramchandren, Radhakrishnan
    Ghosh, Nilanjan
    Munoz, Javier
    Morgan, David S.
    Dang, Nam H.
    Knapp, Mark
    Delioukina, Maria
    Kingsley, Edwin C.
    Anh Tran
    Ping, Jerry
    Beaupre, Darrin M.
    Neuenburg, Jutta K.
    Ruan, Jia
    BLOOD, 2016, 128 (22)
  • [8] Ibrutinib Combined with Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Arm 1+Arm 2 Results from a Multicenter, Open-Label Phase 2 Study
    Fowler, Nathan
    Nastoupil, Loretta
    de Vos, Sven
    Knapp, Mark
    Flinn, Ian W.
    Chen, Robert W.
    Advani, Ranjana H.
    Bhatia, Sumeet
    Martin, Peter
    Mena, Raul
    Suzuki, Samuel
    Beaupre, Darrin M.
    Neuenburg, Jutta K.
    Palomba, M. Lia
    BLOOD, 2016, 128 (22)
  • [9] Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma
    Hanno M. Witte
    Armin Riecke
    Thomas Mayer
    Tobias Bartscht
    Dirk Rades
    Hendrik Lehnert
    Hartmut Merz
    Sebastian Fetscher
    Harald Biersack
    Niklas Gebauer
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 129 - 136
  • [10] Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma
    Witte, Hanno M.
    Riecke, Armin
    Mayer, Thomas
    Bartscht, Tobias
    Rades, Dirk
    Lehnert, Hendrik
    Merz, Hartmut
    Fetscher, Sebastian
    Biersack, Harald
    Gebauer, Niklas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (01) : 129 - 136
12345